01 1MSN Laboratories Private Limited
02 1Piram Healthcare Canada Ltd.
01 1Aging Life Science Co., Ltd.
02 1Ipsen Korea Co., Ltd.
01 2Cabozantinib(S)-malate
01 1India
02 1U.S.A
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2023-05-19
Registration Number : 434-54-ND
Manufacturer Name : MSN Laboratories Private Lim...
Manufacturer Address : Unit-II, Sy. No. 50, Kardanur (Village), Patancheru (Mandal), Sangareddy District, Te...
Registrant Name : Ipsen Korea Co., Ltd.
Registration Date : 2019-04-26
Registration Number : Su183-2-ND
Manufacturer Name : Piram Healthcare Canada Ltd.
Manufacturer Address : 110 Industrial Parkway North Aurora, Ontario, Canada, L4G 3H4
A Cabozantinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cabozantinib, including repackagers and relabelers. The FDA regulates Cabozantinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cabozantinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cabozantinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cabozantinib supplier is an individual or a company that provides Cabozantinib active pharmaceutical ingredient (API) or Cabozantinib finished formulations upon request. The Cabozantinib suppliers may include Cabozantinib API manufacturers, exporters, distributors and traders.
click here to find a list of Cabozantinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cabozantinib Drug Master File in Korea (Cabozantinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cabozantinib. The MFDS reviews the Cabozantinib KDMF as part of the drug registration process and uses the information provided in the Cabozantinib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cabozantinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cabozantinib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cabozantinib suppliers with KDMF on PharmaCompass.
We have 2 companies offering Cabozantinib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?